🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Alabama › Birmingham

Etid klinik pou Sendwòm myelodisplastik nan Birmingham, AL

10 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Ap rekriteFaz 1
  • University of Alabama at Birmingham, Birmingham
4 Weeks – 75 Years · Tout sèks · Mizajou Apr 13, 2026 · NCT06047886

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Ap rekriteFaz 1
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 75 · Tout sèks · Mizajou Mar 4, 2026 · NCT07044544

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Ap rekriteFaz 1
  • University of Alabama O'Neal Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05143996

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Birmingham
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 60 · Tout sèks · Mizajou Oct 8, 2025 · NCT06315309

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 75 · Tout sèks · Mizajou Oct 8, 2025 · NCT06265584

HPC Offered for PRESERVE Expansion

Ap rekriteEtid obsèvasyon
  • University of Alabama, Birmingham, Birmingham
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.